VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $18,152,000 | +62.9% | 781,088 | +11.6% | 0.16% | +38.4% |
| Q1 2018 | $11,142,000 | -42.5% | 699,887 | -24.9% | 0.11% | -17.6% |
| Q4 2017 | $19,365,000 | -31.7% | 931,893 | -52.9% | 0.14% | -47.1% |
| Q3 2017 | $28,353,000 | -19.3% | 1,978,555 | -2.6% | 0.26% | -29.6% |
| Q2 2017 | $35,138,000 | +118.7% | 2,031,094 | +39.4% | 0.36% | +95.2% |
| Q1 2017 | $16,065,000 | -4.6% | 1,456,520 | +25.6% | 0.19% | +14.7% |
| Q4 2016 | $16,844,000 | +19.8% | 1,160,056 | +102.6% | 0.16% | +6.5% |
| Q3 2016 | $14,059,000 | +90.1% | 572,655 | +56.0% | 0.15% | +75.9% |
| Q2 2016 | $7,394,000 | -12.7% | 367,153 | +14.0% | 0.09% | -27.5% |
| Q1 2016 | $8,470,000 | -79.8% | 322,067 | -22.1% | 0.12% | -75.9% |
| Q4 2015 | $42,018,000 | +776.5% | 413,358 | +1815.4% | 0.50% | +641.8% |
| Q2 2015 | $4,794,000 | +131.1% | 21,581 | +106.7% | 0.07% | +103.0% |
| Q1 2015 | $2,074,000 | -25.3% | 10,443 | -46.1% | 0.03% | -21.4% |
| Q4 2014 | $2,775,000 | -65.9% | 19,390 | -68.8% | 0.04% | -66.4% |
| Q3 2014 | $8,144,000 | +10.2% | 62,073 | +5.9% | 0.12% | +9.6% |
| Q2 2014 | $7,391,000 | +34.7% | 58,604 | +40.8% | 0.11% | +23.9% |
| Q1 2014 | $5,488,000 | +1676.1% | 41,633 | +1480.6% | 0.09% | +1740.0% |
| Q4 2013 | $309,000 | -92.3% | 2,634 | -94.4% | 0.01% | -94.9% |
| Q2 2013 | $4,028,000 | – | 46,798 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |